Zum Inhalt

Drugs

Ausgabe 14/2023

Inhalt (9 Artikel)

Pyoderma Gangrenosum: Treatment Options

  • Open Access
  • Therapy in Practice

Joachim Dissemond, Angelo V. Marzano, Philip J. Hampton, Alex G. Ortega-Loayza

Pharmacological Management of Orofacial Pain

  • Review Article

Marcela Romero-Reyes, Sherwin Arman, Antonia Teruel, Satish Kumar, James Hawkins, Simon Akerman

Clinical Outcomes with GLP-1 Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  • Systematic Review

Huilei Zhao, Yang Liu, Menglu Liu, Yi Xu, Qin Ling, Weichun Lin, Jing Zhang, Zhiwei Yan, Jianyong Ma, Weiguang Li, Yujie Zhao, Peng Yu, Xiao Liu, Jingfeng Wang

Ritlecitinib: First Approval

  • Open Access
  • AdisInsight Report

Hannah A. Blair

Delandistrogene Moxeparvovec: First Approval

  • AdisInsight Report

Sheridan M. Hoy

Epcoritamab: First Approval

  • AdisInsight Report

James E. Frampton

Rozanolixizumab: First Approval

  • Open Access
  • AdisInsight Report

Sheridan M. Hoy

Correction to: Remdesivir: A Review in COVID-19

  • Open Access
  • Correction

Hannah A. Blair

Aktuelle Ausgaben